In the field of biomedicine, antibody-dependent cell-mediated cytotoxicity (ADCC) is an important mechanism in tumor immunotherapy. In order to meet the growing research needs, InnoModels Biotechnology has successfully built an in vitro pharmacodynamics platform, of which the ADCC platform has been widely recognized by the industry for its unique features and advantages.
InnoModels' ADCC platform has a diversified experimental service system, which is mainly reflected in its ability to support a variety of types of tumor cells and immune cells in combination experiments. Whether it is tumor cell lines, primary tumor cells or genetically engineered cell lines, the platform can provide appropriate experimental conditions and technical support. Similarly, for effector cells, the platform supports commercially-sourced PBMC (peripheral blood mononuclear cells) as well as clinical patient-sourced PBMC, which provides a rich selection space for researchers to choose the most appropriate cell type according to specific research needs.

In terms of experimental design, InnoModels' ADCC platform focuses on simulating the in vivo environment to more realistically reflect the actual situation of the ADCC process. The platform adopts advanced cell culture technology and flow cytometry technology, which can monitor and record the changes of cells in real-time during the experimental process, effectively differentiate between target cells, count and calculate the proportion of apoptotic cells, and provide researchers with accurate and reliable data support.
It is worth mentioning that InnoModels' ADCC platform is also highly customizable. The platform can be customized according to the specific needs of the researcher, including cell type, drug treatment, experiment time and other aspects. This flexibility enables the platform to meet the diverse needs of different researchers, providing powerful technical support for biomedical research.
In addition, InnoModels' ADCC platform has efficient data processing capabilities. Equipped with an advanced data analysis system, the platform is able to automate the processing and analysis of experimental data, greatly improving the efficiency and accuracy of data processing. Researchers can intuitively understand the experimental results through the visualization reports provided by the platform, thus better guiding the subsequent research work.
Overall, InnoModels' ADCC platform provides powerful technical support for biomedical research with its diverse experimental services, realistic simulation environment, high degree of customizability, and efficient data processing capabilities. In the future, with the continuous development of the biomedical field, InnoModels' ADCC platform will play a greater role in promoting the progress of biomedical research.